Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
T De Witte, D Bowen, M Robin… - Blood, The Journal …, 2017 - ashpublications.org
An international expert panel, active within the European Society for Blood and Marrow
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Transplantation, European LeukemiaNet, Blood and Marrow Transplant Clinical Trial Group …
Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome
N Kröger - Blood, The Journal of the American Society of …, 2012 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (SCT) is well accepted as a curative
treatment approach for younger patients with myelodysplastic syndrome (MDS) and has …
treatment approach for younger patients with myelodysplastic syndrome (MDS) and has …
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia
ZY Lim, R Brand, R Martino, A van Biezen… - Journal of Clinical …, 2010 - ascopubs.org
Purpose This study was performed to examine the characteristics of transplant activity for
patients with myelodysplastic syndromes (MDS) older than 50 years within the European …
patients with myelodysplastic syndromes (MDS) older than 50 years within the European …
[HTML][HTML] Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS
Although allogeneic hematopoietic cell transplantation (HCT) has proven curative potential
for myelodysplastic syndrome, relapse after HCT remains a problem. Pretransplantation …
for myelodysplastic syndrome, relapse after HCT remains a problem. Pretransplantation …
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS
HJ Deeg, BL Scott, M Fang… - Blood, The Journal …, 2012 - ashpublications.org
Clonal cytogenetic abnormalities are a major risk factor for relapse after hematopoietic cell
transplantation (HCT) for myelodysplastic syndrome (MDS). We determined the impact of the …
transplantation (HCT) for myelodysplastic syndrome (MDS). We determined the impact of the …
Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant
Y Wang, HX Wang, YR Lai, ZM Sun, DP Wu, M Jiang… - Leukemia, 2016 - nature.com
Encouraging results from a small sample of patients with myelodysplastic syndrome (MDS)
undergoing haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) must …
undergoing haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) must …
[HTML][HTML] Comparison between upfront transplantation and different pretransplant cytoreductive treatment approaches in patients with high-risk myelodysplastic …
T Schroeder, N Wegener, M Lauseker… - Biology of Blood and …, 2019 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment
for patients with advanced myelodysplastic syndrome (MDS) and secondary acute …
for patients with advanced myelodysplastic syndrome (MDS) and secondary acute …
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
W Saber, CS Cutler, R Nakamura… - Blood, The Journal …, 2013 - ashpublications.org
Allogeneic hematopoietic cell transplantation (HCT) from human leukocyte antigen (HLA)
matched related donor (MRD) and matched unrelated donors (MUD) produces similar …
matched related donor (MRD) and matched unrelated donors (MUD) produces similar …
[HTML][HTML] The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
DM Oliansky, JH Antin, JM Bennett, HJ Deeg… - Biology of Blood and …, 2009 - Elsevier
Clinical research examining the role of hematopoietic stem cell transplantation (SCT) in the
therapy of myelodysplastic syndromes (MDS) in adults is presented and critically evaluated …
therapy of myelodysplastic syndromes (MDS) in adults is presented and critically evaluated …
[HTML][HTML] Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
SA Yahng, M Kim, TM Kim, YW Jeon, JH Yoon… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hypomethylating treatment (HMT) has been suggested as a feasible bridge to hematopoietic
stem cell transplantation (HSCT), but controversies exist around influences of HMT response …
stem cell transplantation (HSCT), but controversies exist around influences of HMT response …